参考文献/References:
[1] Ba JH, Wu BQ, Wang YH, et al. Therapeutic plasma exchange and continuous renal replacement therapy for severe hyperthyroidism and multi-organ failure:a case report[J]. World J Clin Cases,2019,7(4):500-507.DOI:10.12998/wjcc.v7.i4.500.
[2] Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology of hyperthyroidism and hypothyroidism[J]. Nat Rev Endocrinol,2018, 14(5): 301-316.DOI:10.1038/nrendo.2018.18.
[3] Keklik M, Kaynar L, Yilmaz M, et al. The results of therapeutic plasma exchange in patients with severe hyperthyroidism: a retrospective multicenter study[J]. Transfus Apher Sci, 2013, 48(3): 327-330.DOI:10.1016/j.transci.2013.04.010.
[4] 王平. 甲亢的饮食调理[J]. 食品与健康, 2012,(4):30-31.
[5] Min SH, Phung A, Oh TJ, et al. Therapeutic plasmapheresis enabling radioactive iodine treatment in a patient with thyrotoxicosis[J].J Korean Med Sci,2015,30(10):1531-1534.DOI:10.3346/jkms.2015.30.10.1531.
[6] Simsir IY, Ozdemir M, Duman S, et al. Therapeutic plasmapheresis in thyrotoxic patients[J]. Endocrine,2018, 62(1): 144-148.DOI:10.1007/s12020-018-1661-x.
[7] Garla V, Kovvuru K, Ahuja S, et al. Severe hyperthyroidism complicated by agranulocytosis treated with therapeutic plasma exchange: case report and review of the literature[J]. Case Rep Endocrinol, 2018, 2018: 4135940.DOI:10.1155/2018/4135940.
[8] Malik S, Russman AN, Katramados AM, et al. Moyamoya syndrome associated with Graves' disease:a case report and review of the literature[J]. J Stroke Cerebrovasc Dis, 2011, 20(6):528-536.DOI:10.1016/j.jstrokecerebrovasdis.2010.03.006.
[9] Wyble AJ, Moore SC, Yates SG. Weathering the storm: a case of thyroid storm refractory to conventional treatment benefiting from therapeutic plasma exchange[J]. J Clin Apher,2018,33(6):678-681.DOI:10.1002/jca.21658.
[10] Candoni A, De Marchi F, Vescini F, et al. Graves' disease thyrotoxicosis and propylthiouracil related agranulocytosis successfully treated with therapeutic plasma exchange and G-CSF followed by total thyroidectomy[J]. Mediterr J Hematol Infect Dis, 2017, 9(1): e2017058.DOI:10.4084/MJHID.2017.058.
[11] Muller C, Perrin P, Faller B, et al. Role of plasma exchange in the thyroid storm[J]. Ther Apher Dial,2011, 15(6):522-531.DOI:10.1111/j.1744-9987.2011.01003.x.
[12] Mcgonigle AM, Tobian A, Zink JL, et al. Perfect storm: therapeutic plasma exchange for a patient with thyroid storm[J]. J Clin Apher,2018, 33(1):113-116.DOI:10.1002/jca.21560.
[13] Zhu L, Zainudin SB, Kaushik M, et al. Plasma exchange in the treatment of thyroid storm secondary to type Ⅱ amiodarone-induced thyrotoxicosis[J]. Endocrinol Diabetes Metab Case Rep,2016, 2016: 160039.DOI:10.1530/EDM-16-0039.
[14] Petry J, Van Schil PE, Abrams P, et al. Plasmapheresis as effective treatment for thyrotoxic storm after sleeve pneumonectomy[J]. Ann Thorac Surg, 2004,77(5):1839-1841.DOI:10.1016/S0003-4975(03)01246-3.
[15] Jha S, Waghdhare S, Reddi R, et al. Thyroid storm due to inappropriate administration of a compounded thyroid hormone preparation successfully treated with plasmapheresis[J]. Thyroid, 2012, 22(12):1283-1286.DOI:10.1089/thy.2011.0353.
[16] Lew WH, Chang CJ, Lin JD, et al. Successful preoperative treatment of a Graves' disease patient with agranulocytosis and hemophagocytosis using double filtration plasmapheresis[J]. J Clin Apher,2011, 26(3):159-161.DOI:10.1002/jca.20282.
[17] Koball S, Hickstein H, Gloger M, et al. Treatment of thyrotoxic crisis with plasmapheresis and single pass albumin dialysis: a case report[J]. Artif Organs, 2010, 34(2):E55-E58.DOI:10.1111/j.1525-1594.2009.00924.x.
[18] Lu J, Samson S, Kass J, et al. Acute psychosis in a pregnant patient with Graves' hyperthyroidism and anti-NMDA receptor encephalitis[J]. BMJ Case Rep, 2015, 2015.DOI:10.1136/bcr-2014-208052.
[19] Fu H, Cheng L, Jin Y, et al. Thyrotoxicosis with concomitant thyroid cancer[J]. Endocr Relat Cancer,2019.DOI:10.1530/ERC-19-0129.
[20] Miljic D, Stojanovic M, Jesic R, et al. Role of plasma exchange in autoimmune hyperthyroidism complicated by severe tiamazol-induced cholestatic jaundice[J]. Transfus Apher Sci, 2013, 49(2):354-356.DOI:10.1016/j.transci.2013.05.007.
相似文献/References:
[1]朱丹,陈国芳,刘超,等.糖尿病患者合并甲状腺功能异常的机制
及其影响[J].国际内分泌代谢杂志,2016,36(03):206.[doi:10.3760/cma.j.issn.1673-4157.2016.03.16]
Zhu Dan*,Chen Guofang,Liu Chao,et al.Mechanisms of diabetes combined with thyroid dysfunction and its influence[J].International Journal of Endocrinology and Metabolism,2016,36(05):206.[doi:10.3760/cma.j.issn.1673-4157.2016.03.16]
[2]韩煦,魏军平.促甲状腺激素受体抗体的检测及其在Graves病
诊疗中的价值[J].国际内分泌代谢杂志,2017,37(02):94.[doi:10.3760/cma.j.issn.1673-4157.2017.02.006]
Han Xu,Wei Junping..Thyroid stimulating hormone receptor antibodies assays and its clinical significance in Graves' disease[J].International Journal of Endocrinology and Metabolism,2017,37(05):94.[doi:10.3760/cma.j.issn.1673-4157.2017.02.006]
[3]朱萍,卫红艳,王坤玲,等.Graves病甲状腺功能亢进症性肝损害的
相关因素分析[J].国际内分泌代谢杂志,2017,37(03):164.[doi:10.3760/cma.j.issn.1673-4157.2017.03.005]
Zhu Ping,Wei Hongyan,Wang Kunling,et al.Related factors of hyperthyroidism-related liver dysfunction in Graves' disease[J].International Journal of Endocrinology and Metabolism,2017,37(05):164.[doi:10.3760/cma.j.issn.1673-4157.2017.03.005]
[4]刘燕晶 张帆.甲状腺功能亢进症性肝损害的发生机制[J].国际内分泌代谢杂志,2019,39(01):34.[doi:10.3760/cma.j.issn.1673-4157.2019.01.008]
Liu Yanjing,Zhang Fan.The pathogenesis of liver damage of hyperthyroidism[J].International Journal of Endocrinology and Metabolism,2019,39(05):34.[doi:10.3760/cma.j.issn.1673-4157.2019.01.008]
[5]刘天琪,张秀英,纪立农.促甲状腺激素受体抗体的检测及应用进展[J].国际内分泌代谢杂志,2021,41(01):5.[doi:10.3760/cma.j.cn121383-20200608-06021]
Liu Tianqi,Zhang Xiuying,Ji Linong..Progression of assay and clinical practice of thyroid stimulating hormone receptor antibody[J].International Journal of Endocrinology and Metabolism,2021,41(05):5.[doi:10.3760/cma.j.cn121383-20200608-06021]
[6]朱航毅,赵一璟,史雨清,等.碳酸锂致肾性尿崩症的研究进展[J].国际内分泌代谢杂志,2022,42(06):485.[doi:10.3760/cma.j.cn121383-20210530-05078]
Zhu Hangyi,Zhao Yijing,Shi Yuqing,et al.Research progress of nephrogenic diabetes insipidus induced by carbonate lithium[J].International Journal of Endocrinology and Metabolism,2022,42(05):485.[doi:10.3760/cma.j.cn121383-20210530-05078]